Novo Nordisk ( , ) manufactures and markets pharmaceutical products and services. Founded in Denmark in 1923, it is one of the world's leading companies in diabetes care, including the products within the area of insulin delivery systems. Novo Nordisk also has a leading position in haemostasis management, growth hormone therapy and hormone replacement therapy.

With headquarters in Denmark, Novo Nordisk has production facilities in six countries, with affiliates or offices in 68 countries. Novo Nordisk employs 23,172 people globally (as of 2006) http://finance.google.com/finance?q=NVO&hl=en.

Novo Nordisk is dedicated to developing its business towards ecological, social and economic sustainability. The company says this commitment is demonstrated through its values and its environmental and social responsibility policies also called the "triple bottom-line".Novo Nordisk founded the World Diabetes foundation to save the lives of those affected by diabetes in developing countries and were instrumental in achieving a UN resolution to fight diabetes. Making diabetes the only other disease alongside HIV AIDs to have a commintment to combat at a UN level. Such is diabetes present and future danger to human health on a global scale.